Publication:
Omalizumab versus cyclosporin-a for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?

Simple item page
dc.contributor.authorKocatürk, Emek
dc.contributor.authorEngin, B.
dc.contributor.authorÖzdemir, Mehmet Akif
dc.contributor.authorKüçük, Özlem Su
dc.contributor.authorCan, Pelin
dc.contributor.authorÖrnek, Serdar
dc.contributor.authorHasal, Eda
dc.contributor.authorAtakan, Nilgün
dc.contributor.buuauthorBaskan, E. B.
dc.contributor.buuauthorBÜLBÜL BAŞKAN, EMEL
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentDeri ve Zührevi Hastalıklar Ana Bilim Dalı
dc.contributor.orcid0000-0003-2801-0959
dc.contributor.orcid0000-0002-1140-9261
dc.contributor.orcid0000-0002-9124-5817
dc.contributor.researcheridAAF-9330-2019
dc.contributor.researcheridJTD-2412-2023
dc.contributor.researcheridFZP-3964-2022
dc.contributor.researcheridBBC-4116-2021
dc.contributor.researcheridEJK-7570-2022
dc.date.accessioned2024-11-26T06:05:01Z
dc.date.available2024-11-26T06:05:01Z
dc.date.issued2019-08-01
dc.descriptionBu çalışma, 01-05, Temmuz 2019 tarihleri arasında Lisbon[Portekiz]’da düzenlenen Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)’da bildiri olarak sunulmuştur.
dc.description.sponsorshipEuropean Acad Allergy & Clin Immunol
dc.identifier.endpage485
dc.identifier.issn0105-4538
dc.identifier.startpage484
dc.identifier.urihttps://hdl.handle.net/11452/48479
dc.identifier.volume74, Supplement 106, Special Issue SI
dc.identifier.wos000480254003224
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherWiley
dc.relation.journalAllergy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectImmunology
dc.subjectAllergy
dc.titleOmalizumab versus cyclosporin-a for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Deri ve Zührevi Hastalıklar Ana Bilim Dalı
relation.isAuthorOfPublication5bd3accb-bb59-411b-8d6c-46d06d35b5a4
relation.isAuthorOfPublication.latestForDiscovery5bd3accb-bb59-411b-8d6c-46d06d35b5a4

Files

Collections

Yeni Yayınlar